Source:http://linkedlifedata.com/resource/pubmed/id/12042673
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2002-6-3
|
pubmed:abstractText |
A common polymorphism in a folate-metabolizing gene, methylenetetrahydrofolate reductase (MTHFR) 677C>T has been associated with reduced risk of colorectal cancer. In this study, we investigated whether a second common polymorphism of the gene, MTHFR 1298A>C, is an independent risk factor for colorectal cancer and if it is associated with plasma folate and total homocysteine (tHcy) levels. We also examined whether the 677C>T and 1298A>C polymorphisms are in linkage disequilibrium and whether combined heterozygosity confers additional (or reduced) risk of colorectal cancer. We conducted a nested case-control study of 211 incident colorectal cancer cases and 343 controls in the prospective Physicians' Health Study. The MTHFR 677C>T and 1298A>C polymorphisms were in linkage disequilibrium in this population. Compared to MTHFR 1298AA genotype, multivariate-adjusted relative risk of colorectal cancer was 0.73 (95% CI 0.37-1.43) for the MTHFR 1298CC genotype. The slight reduction in risk was not a result of its linkage disequilibrium with the 677C>T polymorphism. This polymorphism was not significantly correlated with the plasma folate and tHcy levels. The combined heterozygosity did not modify the cancer risk; nor did it change the plasma folate and tHcy significantly. We conclude that the MTHFR 1298A>C polymorphism is a less substantial independent risk factor for colorectal cancer compared to the 677C>T polymorphism.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0960-314X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
339-42
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12042673-Case-Control Studies,
pubmed-meshheading:12042673-Colorectal Neoplasms,
pubmed-meshheading:12042673-Double-Blind Method,
pubmed-meshheading:12042673-Folic Acid,
pubmed-meshheading:12042673-Gene Frequency,
pubmed-meshheading:12042673-Genotype,
pubmed-meshheading:12042673-Humans,
pubmed-meshheading:12042673-Incidence,
pubmed-meshheading:12042673-Linkage Disequilibrium,
pubmed-meshheading:12042673-Male,
pubmed-meshheading:12042673-Methylenetetrahydrofolate Reductase (NADPH2),
pubmed-meshheading:12042673-Oxidoreductases Acting on CH-NH Group Donors,
pubmed-meshheading:12042673-Polymorphism, Genetic,
pubmed-meshheading:12042673-Prospective Studies,
pubmed-meshheading:12042673-Questionnaires
|
pubmed:year |
2002
|
pubmed:articleTitle |
Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer.
|
pubmed:affiliation |
Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY, USA. jia.chen@mssm.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|